Hypertension in Cancer Patients and Survivors: Epidemiology

$ 19.00

4.7
(329)
In stock
Description

Blood pressure control with renin–angiotensin system inhibitors in hypertension patients with cancer - good or bad?

Frontiers Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors

Frontiers Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors

The Role of Primary ASCVD Prevention Among Patients Newly Diagnosed With Cancer - American College of Cardiology

Polygenic Risk Scores Predict Hypertension Onset and

Frontiers Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management, Cardio-Oncology

Full article: Cardiotoxicity in pediatric lymphoma survivors

Hypertension Cancer Patients and Survivors - Cardio-Oncologia

Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management, Cardio-Oncology

卵巢癌患者不容忽视!它是潜伏在癌症患者体内的另一杀手…… - 知乎

JCM, Free Full-Text

Hypertension in Cancer Patients

Diet and liver cancer risk: a narrative review of epidemiological evidence, British Journal of Nutrition

The Role of Primary ASCVD Prevention Among Patients Newly Diagnosed With Cancer - American College of Cardiology